Sarah Nemec - 23 Jul 2024 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
VP, Finance and PAO
Signature
/s/ William P. Quinn, Attorney-in-Fact
Issuer symbol
BOLT
Transactions as of
23 Jul 2024
Net transactions value
$0
Form type
4
Filing time
24 Jul 2024, 17:17:51 UTC
Previous filing
15 May 2024
Next filing
05 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 23 Jul 2024 Common Stock 50,000 $0.7301 Direct F1
transaction BOLT Stock Option (Right to Buy) Award $0 +90,000 $0.000000 90,000 23 Jul 2024 Common Stock 90,000 $0.7301 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.
F2 For so long as the Reporting Person continuously provides services to the Issuer this option will vest on July 15, 2025.